Journal
MEDICAL CLINICS OF NORTH AMERICA
Volume 91, Issue 4, Pages 537-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.mcna.2007.03.007
Keywords
-
Categories
Funding
- NHLBI NIH HHS [K24 HL068765, R01 HL059205, K24 HL 68765, R01 HL 59205, R01 HL059205-09, K24 HL068765-05] Funding Source: Medline
Ask authors/readers for more resources
Myocardial infarction is a key component of the burden of cardiovascular disease. The assessment of the incidence and case fatality of myocardial infarction are important determinants of the decline in coronary disease mortality. The change in biomarkers used to diagnose myocardial infarction raises several methodologic, clinical, and public health challenges, which are discussed herein.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
